Aristeia Capital’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$199K Sell
11,863
-12,118
-51% -$170K ﹤0.01% 560
2026
Q1
$286K Buy
+23,981
New +$344K 0.01% 435
2025
Q4
Sell
-11,645
Closed -$252K 689
2025
Q3
$252K Sell
11,645
-103
-0.9% -$2.3K 0.01% 359
2025
Q2
$261K Buy
+11,748
New +$261K 0.01% 325

Other funds holding SGRY

Aristeia Capital's SGRY Position: Q2 2026 in Review

Aristeia Capital reduced its Surgery Partners (SGRY) stake by 51% in Q2 2026, selling an estimated $170K and leaving 11,863 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #560.

Aristeia Capital first reported a position in SGRY in Q2 2025 and has held it in 4 quarters since. The position peaked at $286K in Q1 2026. 188 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Aristeia Capital held 11,863 shares of Surgery Partners worth $199K as of Q2 2026.
  • Aristeia Capital sold 12,118 Surgery Partners shares in Q2 2026, an estimated $170K.
  • Surgery Partners made up ﹤0.01% of Aristeia Capital's portfolio in Q2 2026, its #560 holding.
  • Aristeia Capital first reported a position in Surgery Partners in Q2 2025 and has held it in 4 quarters since.
  • Aristeia Capital's Surgery Partners position peaked at $286K in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.